GSA Capital Partners’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,170
| Closed | -$79K | – | 1807 |
|
|
2022
Q1 | $79K | Buy |
+4,170
| New | +$79K | 0.01% | 1318 |
|
|
2021
Q4 | – | Sell |
-5,870
| Closed | -$218K | – | 1811 |
|
|
2021
Q3 | $218K | Sell |
5,870
-673
| -10% | -$25K | 0.02% | 1196 |
|
|
2021
Q2 | $389K | Sell |
6,543
-2,963
| -31% | -$176K | 0.04% | 788 |
|
|
2021
Q1 | $637K | Buy |
9,506
+1,804
| +23% | +$121K | 0.11% | 238 |
|
|
2020
Q4 | $466K | Buy |
7,702
+5,956
| +341% | +$360K | 0.08% | 460 |
|
|
2020
Q3 | $138K | Sell |
1,746
-452
| -21% | -$35.7K | 0.02% | 1082 |
|
|
2020
Q2 | $137K | Buy |
2,198
+225
| +11% | +$14K | 0.08% | 434 |
|
|
2020
Q1 | $105K | Sell |
1,973
-1,922
| -49% | -$102K | 0.03% | 890 |
|
|
2019
Q4 | $471K | Buy |
3,895
+3,651
| +1,496% | +$441K | 0.05% | 695 |
|
|
2019
Q3 | $44K | Buy |
+244
| New | +$44K | 0.01% | 1329 |
|
|
2018
Q2 | – | Sell |
-2,354
| Closed | -$573K | – | 1940 |
|
|
2018
Q1 | $573K | Buy |
2,354
+1,726
| +275% | +$420K | 0.03% | 995 |
|
|
2017
Q4 | $190K | Sell |
628
-1,368
| -69% | -$414K | 0.01% | 1421 |
|
|
2017
Q3 | $528K | Buy |
+1,996
| New | +$528K | 0.04% | 939 |
|
|
2016
Q2 | – | Sell |
-812
| Closed | -$260K | – | 1925 |
|
|
2016
Q1 | $260K | Buy |
812
+494
| +155% | +$158K | 0.02% | 1376 |
|
|
2015
Q4 | $165K | Buy |
+318
| New | +$165K | 0.01% | 1677 |
|
|
2015
Q1 | – | Sell |
-315
| Closed | -$70K | – | 2215 |
|
|
2014
Q4 | $70K | Sell |
315
-567
| -64% | -$126K | ﹤0.01% | 1617 |
|
|
2014
Q3 | $205K | Buy |
+882
| New | +$205K | 0.01% | 1512 |
|